0001628280-22-000182.txt : 20220104
0001628280-22-000182.hdr.sgml : 20220104
20220104161704
ACCESSION NUMBER: 0001628280-22-000182
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20220104
DATE AS OF CHANGE: 20220104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hagan Joseph P
CENTRAL INDEX KEY: 0001465278
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36421
FILM NUMBER: 22506156
MAIL ADDRESS:
STREET 1: 3344 N. TORREY PINES COURT, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001600620
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA BC
STATE: A1
ZIP: V8Z 7X8
BUSINESS PHONE: 250-708-4272
MAIL ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA BC
STATE: A1
ZIP: V8Z 7X8
4
1
wf-form4_164133098196321.xml
FORM 4
X0306
4
2022-01-03
0
0001600620
Aurinia Pharmaceuticals Inc.
AUPH
0001465278
Hagan Joseph P
#1203-4464 MARKHAM STREET
VICTORIA
A1
V8Z7X8
BRITISH COLUMBIA, CANADA
1
0
0
0
Common Stock
2022-01-03
4
M
0
40000
5.08
A
43500
D
Common Stock
2022-01-03
4
S
0
39366
22.58
D
4134
D
Common Stock
2022-01-03
4
S
0
634
23.29
D
3500
D
Stock Option (right to buy)
5.08
2022-01-03
4
M
0
40000
0
D
2028-02-08
Common Stock
40000.0
10000
D
Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.27 to $23.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The shares subject to the option are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date.
/s/ Joseph P. Hagan
2022-01-04